Evidence map›Paper›PMID 36677711›Full record

ArticleMolecules (Basel, Switzerland)2023

Photocatalytic Activity of the V

Sanja J Armaković, Aleksandra Jovanoski Kostić, Andrijana Bilić, Maria M Savanović, Nataša Tomić, Aleksandar Kremenović, Maja Šćepanović, Mirjana Grujić-Brojčin, Jovana Ćirković, Stevan Armaković

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 13 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sanja J ArmakovićUniversity of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, 21000 Novi Sad, Serbia.ORCID 0000-0002-3665-1046
Aleksandra Jovanoski KostićUniversity of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, 21000 Novi Sad, Serbia.
Andrijana BilićUniversity of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, 21000 Novi Sad, Serbia.ORCID 0000-0002-2912-7318
Maria M SavanovićUniversity of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, 21000 Novi Sad, Serbia.ORCID 0000-0003-3907-6259
Nataša TomićCenter for Solid State and New Materials, Institute of Physics Belgrade, 11000 Belgrade, Serbia.
Aleksandar KremenovićLaboratory of Crystallography, Faculty of Mining and Geology, University of Belgrade, Đušina 7, 11000 Belgrade, Serbia.ORCID 0000-0001-8845-2332
Maja ŠćepanovićCenter for Solid State and New Materials, Institute of Physics Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-6791-5622
Mirjana Grujić-BrojčinCenter for Solid State and New Materials, Institute of Physics Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-6900-3785
Jovana ĆirkovićInstitute for Multidisciplinary Research, University of Belgrade, 11000 Belgrade, Serbia.
Stevan ArmakovićUniversity of Novi Sad, Faculty of Sciences, Department of Physics, 21000 Novi Sad, Serbia.ORCID 0000-0002-8049-9969
University of Novi Sad · RSUniversity of Belgrade · RSInstitute of Physics Belgrade · RS

Funding

Innovation Fund of the Republic of Serbia - Proof of Concept (PoC) ID5619, the Institute of Phys-ics, University of Belgrade, Serbia ID5619Ministry of Education, Science and Technological Development of the Republic of Serbia 451-03-68/2022-14/200125Ministry of Education, Science and Technological Development of the Republic of Serbia 451-03-68/2022-14/200126
6 · The paper itself

Abstract

Due to the inability of conventional wastewater treatment procedures to remove organic pharmaceutical pollutants, active pharmaceutical components remain in wastewater and even reach tap water. In terms of pharmaceutical pollutants, the scientific community focuses on β-blockers due to their extensive (over)usage and moderately high solubility. In this study, the photocatalytic activity of V2O5 was investigated through the degradation of nadolol (NAD), pindolol (PIN), metoprolol (MET), and their mixture under ultraviolet (UV) irradiation in water. For the preparation of V2O5, facile hydrothermal synthesis was used. The structural, morphological, and surface properties and purity of synthesized V2O5 powder were investigated by scanning electron microscopy (SEM), X-ray, and Raman spectroscopy. SEM micrographs showed hexagonal-shaped platelets with well-defined morphology of materials with diameters in the range of 10−65 µm and thickness of around a few microns. X-ray diffraction identified only one crystalline phase in the sample. The Raman scattering measurements taken on the catalyst confirmed the result of XRPD. Degradation kinetics were monitored by ultra-fast liquid chromatography with diode array detection. The results showed that in individual solutions, photocatalytic degradation of MET and NAD was relatively insignificant (<10%). However, in the PIN case, the degradation was significant (64%). In the mixture, the photodegradation efficiency of MET and NAD slightly increased (15% and 13%). Conversely, it reduced the PIN to the still satisfactory value of 40%. Computational analysis based on molecular and periodic density functional theory calculations was used to complement our experimental findings. Calculations of the average local ionization energy indicate that the PIN is the most reactive of all three considered molecules in terms of removing an electron from it.

Indexed as

DFT analysismetoprololnadololnanomaterial characterizationphotocatalysispindololβ-blocker

Identifiers

PMID36677711
PMCPMC9863256
OpenAlexW4313891740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.